Clinical Trial Update: Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands

View source ↗

Summary

This clinical trial update reports a switch from premixed human insulin to biphasic insulin aspart in patients with Type 2 diabetes in the Netherlands. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)
• Premixed human insulin (human insulin premixed formulation)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED